Cart is empty A breakthrough study, led by scientists at Waipapa Taumata Rau, University of Auckland, has uncovered how daylight can boost the immune system’s ability to fight infections.
Single-cell RNA sequencing of bone metastases from multiple cancer types reveals three distinct immune archetypes
Bone is a common site for metastasis of solid cancers, but histological and molecular features of bone metastases are not well understood. In a new study published in Cell Genomics, researchers at Baylor College of Medicine and the University of Texas MD Anderson Cancer Center use RNA sequencing to characterize bone metastases from eight cancer types. The findings identify three distinct immune ecosystem archetypes.
Millions still lack access to glasses—study shows minimal progress in coverage since 2010
Millions of people across the world still lack access to basic eye care such as glasses, according to a new study led by Professor Rupert Bourne of Anglia Ruskin University (ARU).
Chatbots perceived as more judgmental than human mental health provider counterparts, study suggests
Recognizing that some people facing mental health issues are not turning to traditional providers for assistance, a Temple University associate professor has examined how artificial intelligence could be leveraged to help improve access to health care resources.
Timing and consistency of activity linked to better fitness in older adults
Some people spring into action at dawn, while others prefer a slower start to their day. Whether you rise with a grin or a groan, scientists say your internal clock—known as the circadian rhythm—might influence that behavior and much more.
Novel long noncoding RNA may serve as therapeutic target for prostate cancer
Northwestern Medicine investigators have discovered that a novel long noncoding RNA (lncRNA), which are usually 200 nucleotides longer than typical RNAs and are widely expressed in cells, could serve as a prognostic biomarker and therapeutic target for prostate cancer, according to a recent study published in Science Advances.
Weight loss linked to nerve cells in the brain
Semaglutide belongs to a group of drugs called GLP-1R agonists and has been shown to effectively reduce food intake and body weight. The drug is already well established as part of the treatment for obesity and type 2 diabetes, but can cause side effects such as nausea and muscle loss.
Enzalutamide helps extend life for men with advanced prostate cancer, five-year follow-up finds
The combination of enzalutamide with androgen deprivation therapy (ADT) significantly increases the chance of five-year survival for men with metastatic hormone-sensitive prostate cancer, according to a five-year follow-up of the global ARCHES study led by the Duke Cancer Institute.
Cell therapy for patients with amyotrophic lateral sclerosis shows promise in human trials
Dr. Simrit Parmar, an associate professor in the College of Medicine at Texas A&M University and founder of the clinical-stage biotech company Cellenkos Inc. in Houston, has invented a new cell therapy that shows strong promise for the treatment of amyotrophic lateral sclerosis (ALS), aplastic anemia and other devastating diseases.
White House report blames toxins, food and screens for poor health
A new White House report says today’s children are the sickest generation in U.S. history when it comes to chronic disease, and it puts the blame on environmental toxins, poor nutrition and too much screen time.